| Status: Under consideration by AWMSG Scrutiny Panel | |
Treatment of hypoactive sexual desire dysfunction (HSDD) in postmenopausal women on optimised hormone replacement therapy (HRT). |
|
Medicine details |
|
| Medicine name | testosterone (AndroFeme®) |
| Formulation | 10 mg/ml cream |
| Reference number | 921 |
| Indication | As above |
| Company | Andro Pharmaceuticals Ltd |
| BNF chapter | Endocrine system |
| Assessment type | Under consideration |
| Status | Under consideration by AWMSG Scrutiny Panel |
| Scrutiny Panel meeting date | 18/12/2025 |